Daniel, Lisel L.
HRN: 27-09-38 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
CEFUROXIME 1.5GM (VIAL)
08/31/2025
09/06/2025
IV
1.5g
Q8
Internal Hemorrhoids, Gr.4 For Elective OR
Checking Initial Appropriateness
08/31/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/31/2025
09/06/2025
IV
500mg
Q8
Internal Hemorrhoid
Checking Initial Appropriateness